V

Vir Biotechnology

D
VIR
USD
-0.335
(-3.7305%)
Market Closed
37,095.00
حجم التداول
-3.05
الربح لكل سهم
-
العائد الربحي
-2.414804
P/E
1,181,249,091.30
حجم السوق
اليوم
-3.7305%
1 اسبوع
-11.560%
1 شهر
12.638%
6 اشهر
-14.236%
12 اشهر
-12.544%
بداية السنة
-13.980%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Vir Biotechnology

Sector:
Healthcare
Industry:
Biotechnology
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development,collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
هل تحتاج مساعدة او لديك استفسار؟